Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a small update to the page's versioning. There are no visible changes to the study data, eligibility criteria, or outcomes on the page.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page is updated to reflect a new ClinicalTrials.gov interface/release revision number (from v3.5.2 to v3.5.3). This represents a site maintenance/version change rather than a change to the underlying study information.SummaryDifference0.1%

- Check48 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3; no visible changes to the study details or page layout.SummaryDifference0.1%

- Check113 days agoChange DetectedRevision history updated for study documents: added revision v3.4.2 and removed v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.